Bone Biologics Corp BBLG
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $1.11
- Day Range
- $1.09–1.12
- 52-Week Range
- $1.05–4.13
- Bid/Ask
- $1.09 / $1.12
- Shares Outstanding
- 1.80M
- Market Cap
- $1.96M
- Volume/Avg
- 24,700 / 58,018
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 2
- Website
- https://www.bonebiologics.com
Valuation
|
Metric
|
BBLG
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.43 |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
BBLG
|
|---|---|
Quick Ratio | 14.67 |
Current Ratio | 16.09 |
Interest Coverage | — |
Quick Ratio
BBLG
Profitability
|
Metric
|
BBLG
|
|---|---|
Return on Assets (Normalized) | −48.21% |
Return on Equity (Normalized) | −51.46% |
Return on Invested Capital (Normalized) | −54.21% |
Return on Assets
BBLG
Biotechnology Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc
VRTX
| LOCK|%QD%KM | LOCK|&^F@# | $122B | |||
| Regeneron Pharmaceuticals Inc
REGN
| LOCK|plvQtMC | LOCK|TR<N? | $71B | |||
| argenx SE ADR
ARGX
| LOCK|m>#k$j& | LOCK|X@x | $54B | |||
| BeOne Medicines Ltd ADR
ONC
| LOCK|cdjx&^ | LOCK|Q& | $37B | |||
| Alnylam Pharmaceuticals Inc
ALNY
| LOCK|Zw?g&LW | LOCK|&<c@ | $36B | |||
| Royalty Pharma PLC Class A
RPRX
| LOCK|>S>@^C?< | LOCK|w?n> | $26B | |||
| Moderna Inc
MRNA
| LOCK|Gq?t>?d | LOCK|t^< | $24B | |||
| Incyte Corp
INCY
| LOCK|QHtj^! | LOCK|^$! | $23B | |||
| BioNTech SE ADR
BNTX
| LOCK|#XQqsC? | LOCK|$& | $23B | |||
| BridgeBio Pharma Inc
BBIO
| LOCK|Cn%MdG$ | LOCK|^zf | $16B |
United States